BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808-18; discussion 819. [PMID: 10615936 DOI: 10.1097/00000658-199912000-00010] [Cited by in Crossref: 490] [Cited by in F6Publishing: 386] [Article Influence: 23.3] [Reference Citation Analysis]
Number Citing Articles
1 Bridgewater J, Imber C. New advances in the management of biliary tract cancer. HPB (Oxford) 2007;9:104-11. [PMID: 18333124 DOI: 10.1080/13651820701216216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Giuliante F, Ardito F, Aldrighetti L, Ferrero A, Pinna AD, De Carlis L, Cillo U, Jovine E, Portolani N, Gruttadauria S, Mazzaferro V, Massani M, Rosso E, Ettorre GM, Ratti F, Guglielmi A, Cescon M, Colasanti M, Di Sandro S, Gringeri E, Russolillo N, Ruzzenente A, Sposito C, Zanello M, Zimmitti G; Italian Association of HepatoBilioPancreatic Surgeons-AICEP., Italian Association of Hepato-Biliary-Pancreatic Surgeons-AICEP. Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study. Surgery 2021;170:383-9. [PMID: 33622570 DOI: 10.1016/j.surg.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 2003;27:680-684. [PMID: 12733000 DOI: 10.1007/s00268-003-6656-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
4 Nishio H, Hidalgo E, Hamady ZZ, Ravindra KV, Kotru A, Dasgupta D, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg 2005;242:267-75. [PMID: 16041218 DOI: 10.1097/01.sla.0000171304.70678.11] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
5 Geisel D, Malinowski M, Powerski MJ, Wüstefeld J, Heller V, Denecke T, Stockmann M, Gebauer B. Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol 2014;37:1251-8. [PMID: 24310828 DOI: 10.1007/s00270-013-0810-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
6 Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2012;11:12-7. [PMID: 22251465 DOI: 10.1016/s1499-3872(11)60119-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
7 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/01.sla.0000074984.83031.02] [Cited by in Crossref: 143] [Cited by in F6Publishing: 95] [Article Influence: 7.9] [Reference Citation Analysis]
8 Lee Y, Choi D, Han S, Han IW, Heo JS, Choi SH. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:350-8. [PMID: 30588526 DOI: 10.14701/ahbps.2018.22.4.350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg 2004;239:510-7. [PMID: 15024312 DOI: 10.1097/01.sla.0000118594.23874.89] [Cited by in Crossref: 144] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
10 Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023-4035. [PMID: 20005336 DOI: 10.1016/j.transproceed.2009.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
11 Bednarsch J, Czigany Z, Heij LR, Luedde T, van Dam R, Lang SA, Ulmer TF, Hornef MW, Neumann UP. Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance. Sci Rep 2021;11:2926. [PMID: 33536484 DOI: 10.1038/s41598-021-82378-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol. 2013;5:139-146. [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shimizu H, Sawada S, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Miyazaki M. Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy. Ann Surg. 2009;249:435-439. [PMID: 19247031 DOI: 10.1097/sla.0b013e31819a6c10] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
14 Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K, Morioka D, Maegawa J, Endo I. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Ann Surg Oncol 2016;23:475-84. [PMID: 27387681 DOI: 10.1245/s10434-016-5381-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
15 Bahra M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up. J Hepatobiliary Pancreat Surg 2008;15:501-7. [DOI: 10.1007/s00534-007-1308-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
16 Jo HS, Kim DS, Yu YD, Kang WH, Yoon KC. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study. World J Surg Oncol 2020;18:3. [PMID: 31901228 DOI: 10.1186/s12957-019-1779-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS. In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg. 2004;188:584-588. [PMID: 15546575 DOI: 10.1016/j.amjsurg.2004.07.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nagino M. Cutting edge of an aggressive surgical approach for perihilar cholangiocarcinoma. Updates Surg. 2013;65:81-83. [PMID: 23460256 DOI: 10.1007/s13304-013-0204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Takara D, Sugawara G, Ebata T, Yokoyama Y, Igami T, Nagino M. Preoperative biliary MRSA infection in patients undergoing hepatobiliary resection with cholangiojejunostomy: incidence, antibiotic treatment, and surgical outcome. World J Surg 2011;35:850-7. [PMID: 21327600 DOI: 10.1007/s00268-011-0990-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
20 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Izbicki JR, Tsui TY, Bohn BA, Bockhorn M. Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor). J Gastrointest Surg 2013;17:581-5. [PMID: 23242846 DOI: 10.1007/s11605-012-2109-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
22 Abou-alfa GK, Jarnagin W, El Dika I, D'angelica M, Lowery M, Brown K, Ludwig E, Kemeny N, Covey A, Crane CH, Harding J, Shia J, O'reilly EM. Liver and Bile Duct Cancer. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1314-1341.e11. [DOI: 10.1016/b978-0-323-47674-4.00077-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, Hayashi H, Motoi F, Egawa S. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469. [PMID: 19941010 DOI: 10.1007/s00534-009-0206-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
24 Cormier JN, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol. 2000;16:437-443. [PMID: 17031117 DOI: 10.1097/00001574-200009000-00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, Ando M, Nagino M. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. British Journal of Surgery 2019;106:774-82. [DOI: 10.1002/bjs.11125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
26 Sun HY, Lee JM, Park HS, Yoon JH, Baek JH, Han JK, Choi BI. Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer. J Magn Reson Imaging. 2013;38:138-147. [PMID: 23281093 DOI: 10.1002/jmri.23957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
27 Young AL, Prasad KR, Adair R, Abu Hilal M, Guthrie JA, Lodge JP. Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. J Am Coll Surg 2008;207:e1-6. [PMID: 18954768 DOI: 10.1016/j.jamcollsurg.2008.07.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
28 Laurent A, Tayar C, Cherqui D. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford. ). 2008;10:126-129. [PMID: 18773089 DOI: 10.1080/13651820802007472] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
29 Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, Wilson SD, Demeure MJ, Rilling WS, Dua KS. Improved survival in resected biliary malignancies. Surgery. 2002;132:555-563; discission 563-564. [PMID: 12407338 DOI: 10.1067/msy.2002.127555] [Cited by in Crossref: 132] [Cited by in F6Publishing: 113] [Article Influence: 6.9] [Reference Citation Analysis]
30 Jara M, Reese T, Malinowski M, Valle E, Seehofer D, Puhl G, Neuhaus P, Pratschke J, Stockmann M. Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments. HPB (Oxford). 2015;17:651-658. [PMID: 26058324 DOI: 10.1111/hpb.12424] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 8.4] [Reference Citation Analysis]
31 Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
32 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/00000658-200307000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
33 Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. 2014;40:489-495. [PMID: 24685155 DOI: 10.1016/j.ejso.2014.02.231] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
34 Bouras N, Caudry M, Saric J, Bonnel C, Rullier E, Trouette R, Demeaux H, Maire J. Radiothérapie conformationnelle des cholangiocarcinomes de la voie biliaire principale localement évolués. Cancer/Radiothérapie 2002;6:22-9. [DOI: 10.1016/s1278-3218(01)00144-5] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
35 Ye XW, Hu HJ, Xiong XZ, Lu J, Cheng NS. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma. Surg Today 2021;51:1352-60. [PMID: 33651221 DOI: 10.1007/s00595-021-02249-x] [Reference Citation Analysis]
36 Chouillard EK, Gumbs AA, Cherqui D. Vascular clamping in liver surgery: physiology, indications and techniques. Ann Surg Innov Res. 2010;4:2. [PMID: 20346153 DOI: 10.1186/1750-1164-4-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
37 He X, Zhang S, Zhu X, Wang D, Ma Y, Wang G, Ju W, Wu L, Huang J. Orthotopic liver transplantation with hepatopancreato-duodenectomy for hilar cholangiocarcinoma: . Chinese Medical Journal 2007;120:251-3. [DOI: 10.1097/00029330-200702010-00017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
38 Tan JW, Hu BS, Chu YJ, Tan YC, Ji X, Chen K, Ding XM, Zhang A, Chen F, Dong JH. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg 2013;37:614-21. [PMID: 23283218 DOI: 10.1007/s00268-012-1878-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
39 Paik KY, Choi DW, Chung JC, Kang KT, Kim SB. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1268-1274. [PMID: 18330655 DOI: 10.1007/s11605-008-0503-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
40 Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28:226-231. [PMID: 21540611 DOI: 10.1159/000327361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
41 Liu JG, Wu J, Wang J, Shu GM, Wang YJ, Lou C, Zhang J, Du Z. Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A. 2018;28:1053-1060. [PMID: 29641365 DOI: 10.1089/lap.2017.0744] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
42 Nagino M, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Watanabe N. Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery for locally advanced cholangiocarcinoma: Short- and long-term outcomes of superextended surgery. J Hepatobiliary Pancreat Sci. 2021;28:376-386. [PMID: 33587829 DOI: 10.1002/jhbp.914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 2009;16:3308-15. [PMID: 19774418 DOI: 10.1245/s10434-009-0701-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
44 Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, Chhieng DC, Syed SA, Vickers SM, Mel Wilcox C. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clinical Gastroenterology and Hepatology 2004;2:209-13. [DOI: 10.1016/s1542-3565(04)00005-9] [Cited by in Crossref: 206] [Cited by in F6Publishing: 65] [Article Influence: 12.1] [Reference Citation Analysis]
45 IJitsma AJ, Appeltans BM, de Jong KP, Porte RJ, Peeters PM, Slooff MJ. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg. 2004;8:686-694. [PMID: 15358329 DOI: 10.1016/j.gassur.2004.04.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
46 Rotellar F, Pardo F. Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified? World J Gastrointest Oncol. 2013;5:127-131. [PMID: 23919106 DOI: 10.4251/wjgo.v5.i7.127] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
47 Maguchi H, Takahashi K, Katanuma A, Osanai M, Nakahara K, Matuzaki S, Urata T, Iwano H. Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007;14:441-446. [PMID: 17909711 DOI: 10.1007/s00534-006-1192-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
48 Ramacciato G, D'angelo F, Baldini R, Petrucciani N, Antolino L, Aurello P, Nigri G, Bellagamba R, Pezzoli F, Balesh A, Cucchetti A, Cescon M, Gaudio MD, Ravaioli M, Pinna AD. Hepatocellular Carcinomas and Primary Liver Tumors as Predictive Factors for Postoperative Mortality after Liver Resection: A Meta-Analysis of More than 35,000 Hepatic Resections. The American Surgeon 2012;78:456-67. [DOI: 10.1177/000313481207800438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
49 Otto G. Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis 2007;22:101-8. [PMID: 16575606 DOI: 10.1007/s00384-005-0070-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2014;9:491-502. [DOI: 10.1586/era.09.5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
51 Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery 2018;163:732-8. [PMID: 29336813 DOI: 10.1016/j.surg.2017.08.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
52 Boutros C, Somasundar P, Espat NJ. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009;18:269-88. [DOI: 10.1016/j.soc.2008.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Uno H, Furukawa K, Suzuki D, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Immunonutrition suppresses acute inflammatory responses through modulation of resolvin E1 in patients undergoing major hepatobiliary resection. Surgery. 2016;160:228-236. [PMID: 26965712 DOI: 10.1016/j.surg.2016.01.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
54 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
55 Stauffer JA, Steers JL, Bonatti H, Dougherty MK, Aranda-Michel J, Dickson RC, Harnois DM, Nguyen JH. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl. 2009;15:1728-1737. [PMID: 19938125 DOI: 10.1002/lt.21932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
56 Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nimura Y, Nagino M. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections. Ann Surg. 2015;262:121-129. [PMID: 25405563 DOI: 10.1097/sla.0000000000000827] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 7.2] [Reference Citation Analysis]
57 Brown KM, Geller DA. Proximal Biliary Tumors. Surgical Clinics of North America 2014;94:311-23. [DOI: 10.1016/j.suc.2013.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Khashab MA, Fockens P, Al-haddad MA. Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos). Gastrointestinal Endoscopy 2012;76:1024-33. [DOI: 10.1016/j.gie.2012.04.451] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
59 Mumtaz K, Hamid S, Jafri W. Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgery. Cochrane Database Syst Rev. 2007;CD006001. [PMID: 17636818 DOI: 10.1002/14651858.cd006001.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
60 Machado MA, Makdissi FF, Surjan RC. Right Trisectionectomy with Principle En Bloc Portal Vein Resection for Right-Sided Hilar Cholangiocarcinoma: No-Touch Technique. Ann Surg Oncol 2012;19:1324-5. [DOI: 10.1245/s10434-011-2072-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
61 Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2019;45:1468-1478. [PMID: 31053477 DOI: 10.1016/j.ejso.2019.04.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
62 Banz VM, Inderbitzin D, Fankhauser R, Studer P, Candinas D. Long-Term Quality of Life After Hepatic Resection: Health Is not Simply the Absence of Disease. World J Surg 2009;33:1473-80. [DOI: 10.1007/s00268-009-0032-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
63 Patel T. Cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2006;3:33-42. [DOI: 10.1038/ncpgasthep0389] [Cited by in Crossref: 186] [Cited by in F6Publishing: 161] [Article Influence: 12.4] [Reference Citation Analysis]
64 Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. Ann Surg Oncol. 2019;26:611-618. [PMID: 30539494 DOI: 10.1245/s10434-018-7075-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
65 Hung AY, Canning CA, Patel KM, Holland JM, Kachnic LA. Radiation therapy for gastrointestinal cancer. Hematol Oncol Clin North Am. 2006;20:287-320. [PMID: 16730296 DOI: 10.1016/j.hoc.2006.01.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
66 Cleary SP, Dawson LA, Knox JJ, Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg. 2007;44:396-482. [PMID: 17693325 DOI: 10.1067/j.cpsurg.2007.04.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
67 Baton O, Azoulay D, Adam DV, Castaing D. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg. 2007;204:250-260. [PMID: 17254929 DOI: 10.1016/j.jamcollsurg.2006.10.028] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
68 Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg. 2002;6:617-624. [PMID: 12127130 DOI: 10.1016/s1091-255x(01)00008-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
69 Geisel D, Gebauer B, Malinowski M, Stockmann M, Denecke T. Comparison of CT and MRI artefacts from coils and vascular plugs used for portal vein embolization. European Journal of Radiology 2014;83:692-5. [DOI: 10.1016/j.ejrad.2014.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
70 Turrini O, Ewald J, Barbier L, Mokart D, Blache JL, Delpero JR. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg. 2013;257:726-730. [PMID: 22968078 DOI: 10.1097/sla.0b013e318269d23c] [Cited by in Crossref: 60] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
71 Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194-200. [PMID: 12819970 DOI: 10.1007/s00423-003-0383-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 6.5] [Reference Citation Analysis]
72 Geisel D, Lüdemann L, Fröling V, Malinowski M, Stockmann M, Baron A, Gebauer B, Seehofer D, Prasad V, Denecke T. Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI. Eur Radiol. 2015;25:1384-1391. [PMID: 25447973 DOI: 10.1007/s00330-014-3536-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
73 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
74 Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. British Journal of Surgery 2013;100:388-94. [DOI: 10.1002/bjs.8955] [Cited by in Crossref: 113] [Cited by in F6Publishing: 106] [Article Influence: 12.6] [Reference Citation Analysis]
75 Ramos Rubio E. Radicalidad en la cirugía del colangiocarcinoma hiliar (tumor de Klatskin). Cirugía Española 2007;82:11-5. [DOI: 10.1016/s0009-739x(07)71654-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
77 Kamphues C, Seehofer D, Collettini F, Bahra M, Neuhaus P, Wust P, Denecke T, Gebauer B, Schnapauff D. Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma. HPB (Oxford) 2012;14:791-7. [PMID: 23134179 DOI: 10.1111/j.1477-2574.2012.00537.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Yamada T, Arai T, Nagino M, Oda K, Shoda J, Suzuki H, Sugiyama Y, Nimura Y. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch Surg 2005;390:421-9. [PMID: 15965653 DOI: 10.1007/s00423-005-0564-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
79 Heijnen BH, Straatsburg IH, Gouma DJ, van Gulik TM. Decrease in core liver temperature with 10°C by in situ hypothermic perfusion under total hepatic vascular exclusion reduces liver ischemia and reperfusion injury during partial hepatectomy in pigs. Surgery 2003;134:806-17. [DOI: 10.1016/s0039-6060(03)00125-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
80 Kaiser GM, Mueller AB, Sauerwein W, Zhang HW, Westermann S, Frühauf NR, Kuehne CA, Stuschke M, Oldhafer KJ, Broelsch CE. Biliodigestive anastomosis after intraoperative irradiation in swine. J Invest Surg 2005;18:305-13. [PMID: 16319051 DOI: 10.1080/08941930500328748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
81 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
82 Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005;390:104-13. [PMID: 15711820 DOI: 10.1007/s00423-004-0536-1] [Cited by in Crossref: 162] [Cited by in F6Publishing: 125] [Article Influence: 10.1] [Reference Citation Analysis]
83 Saito H, Noji T, Okamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery 2016;159:842-51. [DOI: 10.1016/j.surg.2015.10.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
84 Miwa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Ogawa S, Soeda J, Miyagawa S. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg. 2007;14:136-141. [PMID: 17384903 DOI: 10.1007/s00534-006-1107-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
85 Giulianotti PC, Sbrana F, Bianco FM, Addeo P. Robot-assisted laparoscopic extended right hepatectomy with biliary reconstruction. J Laparoendosc Adv Surg Tech A. 2010;20:159-163. [PMID: 20201685 DOI: 10.1089/lap.2009.0383] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
86 Nissen NN, Cavazzoni E, Tran TT, Poordad FP. Emerging Role of Transplantation for Primary Liver Cancers: . The Cancer Journal 2004;10:88-96. [DOI: 10.1097/00130404-200403000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
87 Zhimin G, Noor H, Jian-Bo Z, Lin W, Jha RK. Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit. 2013;19:648-656. [PMID: 23921971 DOI: 10.12659/msm.889379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
88 Otsuka S, Kaneoka Y, Maeda A, Takayama Y, Fukami Y, Onoe S. Hepatic Artery Reconstruction with a Continuous Suture Method for Hepato-Biliary-Pancreatic Surgery. World J Surg 2016;40:951-7. [DOI: 10.1007/s00268-015-3310-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
89 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 01.SLA.0000074960.55004.72] [Reference Citation Analysis]
90 Boudjema K, Sulpice L, Garnier S, Bretagne J, Gandon Y, Rohou T. A Simple System to Predict Perihilar Cholangiocarcinoma Resectability. J Gastrointest Surg 2013;17:1247-56. [DOI: 10.1007/s11605-013-2215-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
91 Bednarsch J, Czigany Z, Heise D, Lang SA, Olde Damink SWM, Luedde T, Bruners P, Ulmer TF, Neumann UP. Leakage and Stenosis of the Hepaticojejunostomy Following Surgery for Perihilar Cholangiocarcinoma. J Clin Med 2020;9:E1392. [PMID: 32397289 DOI: 10.3390/jcm9051392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
92 Matsuyama R, Morioka D, Mori R, Yabushita Y, Hiratani S, Ota Y, Kumamoto T, Endo I. Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma. World J Surg 2019;43:1094-104. [PMID: 30536024 DOI: 10.1007/s00268-018-04883-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
93 Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008;15:590-9. [PMID: 18057991 DOI: 10.1245/s10434-007-9687-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
94 Perini MV, Coelho FF, Kruger JA, Rocha FG, Herman P. Extended right hepatectomy with caudate lobe resection using the hilar "en bloc" resection technique with a modified hanging maneuver. J Surg Oncol. 2016;113:427-431. [PMID: 26776500 DOI: 10.1002/jso.24154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
95 Kimbrough CW, Cloyd JM, Pawlik TM. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Review of Anticancer Therapy 2018;18:673-83. [DOI: 10.1080/14737140.2018.1473039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
96 Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. World J Gastroenterol 2017;23:3301-8. [PMID: 28566890 DOI: 10.3748/wjg.v23.i18.3301] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
97 Mehrabi A, Mood ZA, Roshanaei N, Fonouni H, Müller SA, Schmied BM, Hinz U, Weitz J, Büchler MW, Schmidt J. Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg. 2008;207:499-509. [PMID: 18926451 DOI: 10.1016/j.jamcollsurg.2008.05.024] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
98 Zhao Z, Ma J, Wu K, Chen L, Yu J, Hu W, Zhang K. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma. Clin Transl Oncol 2016;18:878-83. [PMID: 26563145 DOI: 10.1007/s12094-015-1449-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Zaydfudim VM, Clark CJ, Kendrick ML, Que FG, Reid-Lombardo KM, Donohue JH, Farnell MB, Nagorney DM. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. Am J Surg 2013;206:159-65. [PMID: 23746658 DOI: 10.1016/j.amjsurg.2012.11.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
100 Han IW, Jang JY, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection. Ann Surg Treat Res 2014;87:87-93. [PMID: 25114888 DOI: 10.4174/astr.2014.87.2.87] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
101 Roos E, Strijker M, Franken LC, Busch OR, van Hooft JE, Klümpen HJ, van Laarhoven HW, Wilmink JW, Verheij J, van Gulik TM, Besselink MG. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. HPB (Oxford) 2020;22:405-14. [PMID: 31494056 DOI: 10.1016/j.hpb.2019.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
102 Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2013;15:492-503. [PMID: 23750491 DOI: 10.1111/j.1477-2574.2012.00616.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
103 Torzilli G, Nagino M, Tzeng CD, Kingham TP, Alatise OI, Ayandipo OO, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JN. SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg 2017;21:175-85. [PMID: 27480411 DOI: 10.1007/s11605-016-3193-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
104 Otto G, Thies J, Hoppe-Lotichius M, Bittinger F, Pitton MB, Hadian A. [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver]. Chirurg 2004;75:59-65. [PMID: 14740129 DOI: 10.1007/s00104-003-0747-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
105 Bednarsch J, Czigany Z, Heij LR, Liu D, den Dulk M, Wiltberger G, Bruners P, Ulmer TF, Neumann UP, Lang SA. Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma. J Clin Med 2021;10:2959. [PMID: 34209368 DOI: 10.3390/jcm10132959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Geisel D, Lüdemann L, Wagner C, Stelter L, Grieser C, Malinowski M, Stockmann M, Seehofer D, Hamm B, Gebauer B, Denecke T. Evaluation of gadolinium-EOB-DTPA uptake after portal vein embolization: value of an increased flip angle. Acta Radiol 2014;55:149-54. [PMID: 23908244 DOI: 10.1177/0284185113495833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
107 Prat F, Lafon C, de Lima DM, Theilliere Y, Fritsch J, Pelletier G, Buffet C, Cathignol D. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study. Gastrointestinal Endoscopy 2002;56:909-15. [DOI: 10.1016/s0016-5107(02)70374-x] [Cited by in Crossref: 42] [Article Influence: 2.2] [Reference Citation Analysis]
108 Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009;13:1470-1479. [PMID: 19421824 DOI: 10.1007/s11605-009-0900-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
109 Wang J, Obulkasim H, Zou X, Liu B, Wu Y, Wu X, Ding Y. Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report. Oncol Lett. 2019;17:2069-2074. [PMID: 30719105 DOI: 10.3892/ol.2018.9878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Talreja JP, Kahaleh M. Photodynamic therapy for cholangiocarcinoma. Gut Liver. 2010;4 Suppl 1:S62-S66. [PMID: 21103297 DOI: 10.5009/gnl.2010.4.s1.s62] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
111 Hu HJ, Wu ZR, Jin YW, Ma WJ, Yang Q, Wang JK, Liu F, Li FY. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives. ANZ J Surg. 2019;89:476-480. [PMID: 30136376 DOI: 10.1111/ans.14765] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
112 Paul A, Kaiser GM, Molmenti EP, Schroeder T, Vernadakis S, Oezcelik A, Baba HA, Cicinnati VR, Sotiropoulos GC. Klatskin Tumors and the Accuracy of the Bismuth-Corlette Classification. The American Surgeon 2011;77:1695-9. [DOI: 10.1177/000313481107701246] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
113 Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Onoe S. Major hepatopancreatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer. Langenbecks Arch Surg. 2016;401:471-478. [PMID: 27023217 DOI: 10.1007/s00423-016-1413-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
114 Taniguchi K, Tabata M, Iida T, Hori T, Yagi S, Uemoto S. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 2006;32:208-12. [PMID: 16377119 DOI: 10.1016/j.ejso.2005.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
115 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
116 Geisel D, Lüdemann L, Keuchel T, Malinowski M, Seehofer D, Stockmann M, Hamm B, Gebauer B, Denecke T. Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI. Eur Radiol 2013;23:2555-60. [PMID: 23652847 DOI: 10.1007/s00330-013-2859-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
117 Slivka A, Gan I, Jamidar P, Costamagna G, Cesaro P, Giovannini M, Caillol F, Kahaleh M. Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study. Gastrointest Endosc. 2015;81:282-290. [PMID: 25616752 DOI: 10.1016/j.gie.2014.10.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 46] [Article Influence: 11.7] [Reference Citation Analysis]
118 Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-699; discussion 699-702. [PMID: 15849505 DOI: 10.1097/01.sla.0000160701.38945.82] [Cited by in Crossref: 245] [Cited by in F6Publishing: 206] [Article Influence: 15.3] [Reference Citation Analysis]
119 Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56-64. [PMID: 19937985 DOI: 10.1002/bjs.6788] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
120 Shah SR. Issues in surgery for hilar cholangiocarcinoma. Indian J Surg 2012;74:87-90. [PMID: 23372312 DOI: 10.1007/s12262-011-0382-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Annovazzi A, Peeters M, Maenhout A, Signore A, Dierckx R, Van De Wiele C. 18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology 2003;125:1235-45. [PMID: 14517805 DOI: 10.1016/s0016-5085(03)01208-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
122 Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB. Liver Transplantation for Cholangiocarcinoma. Transplantation 2009;88:295-8. [DOI: 10.1097/tp.0b013e3181adc9e5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
123 Kuriyama N, Usui M, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Tanemura A, Kishiwada M, Sakurai H, Mizuno S, Isaji S. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer 2020;20:405. [PMID: 32393197 DOI: 10.1186/s12885-020-06895-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Seyama Y, Kokudo N, Makuuchi M. Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy. Surgical Oncology Clinics of North America 2009;18:339-59. [DOI: 10.1016/j.soc.2008.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113-121. [PMID: 16467211 DOI: 10.1148/radiol.2383050419] [Cited by in Crossref: 139] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
126 Pavey DA, Gress FG. The role of EUS-guided FNA for the evaluation of biliary strictures. Gastrointest Endosc. 2006;64:334-337. [PMID: 16923478 DOI: 10.1016/j.gie.2006.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
127 Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230-239. [PMID: 16858185 DOI: 10.1097/01.sla.0000217639.10331.47] [Cited by in Crossref: 201] [Cited by in F6Publishing: 154] [Article Influence: 13.4] [Reference Citation Analysis]
128 Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514. [PMID: 28551378 DOI: 10.1016/j.surg.2017.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
129 Blechacz BR, Gores GJ. Cholangiocarcinoma. Clinics in Liver Disease 2008;12:131-50. [DOI: 10.1016/j.cld.2007.11.003] [Cited by in Crossref: 156] [Cited by in F6Publishing: 138] [Article Influence: 12.0] [Reference Citation Analysis]
130 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
131 Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007;141:581-588. [PMID: 17462457 DOI: 10.1016/j.surg.2006.09.016] [Cited by in Crossref: 161] [Cited by in F6Publishing: 136] [Article Influence: 11.5] [Reference Citation Analysis]
132 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72.] [Reference Citation Analysis]
133 Dokmak S, Belghiti J. Which limits to the “ALPPS” approach? Ann Surg. 2012;256:e6; author reply e16-e17. [PMID: 22895355 DOI: 10.1097/sla.0b013e318265fd64] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
134 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
135 Berumen J, Hemming A. Vascular Reconstruction in Hepatic Malignancy. Surg Clin North Am 2016;96:283-98. [PMID: 27017865 DOI: 10.1016/j.suc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
136 Robles R, Parrilla P, Ramírez P, Sánchez-Bueno F, Marín C, Pastor P, Pons JA, Acosta F, Pérez-Flores D, De La Peña Morales J. [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour]. Cir Esp 2010;87:82-8. [PMID: 20074713 DOI: 10.1016/j.ciresp.2009.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
137 Rela M, Rajalingam R, Shanmugam V, O' Sullivan A, Reddy MS, Heaton N. Novel en-bloc resection of locally advanced hilar cholangiocarcinoma: the Rex recess approach. Hepatobiliary Pancreat Dis Int 2014;13:93-7. [PMID: 24463086 DOI: 10.1016/s1499-3872(14)60013-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
138 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 19.8] [Reference Citation Analysis]
139 Mizuno T, Ebata T, Nagino M. Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches. Surg Oncol. 2020;33:201-206. [PMID: 31301935 DOI: 10.1016/j.suronc.2019.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
140 Bednarsch J, Czigany Z, Lurje I, Tacke F, Strnad P, Ulmer TF, Gaisa NT, Bruners P, Neumann UP, Lurje G. Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma. HPB22:437-444. [PMID: 31383591 DOI: 10.1016/j.hpb.2019.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
141 Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, López P, Gómez M, de Vicente E, Loinaz C, Santoyo J, Fleitas M, Bernardos A, Lladó L, Ramírez P, Bueno FS, Jaurrieta E, Parrilla P. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-71. [PMID: 14745336 DOI: 10.1097/01.sla.0000108702.45715.81] [Cited by in Crossref: 194] [Cited by in F6Publishing: 156] [Article Influence: 11.4] [Reference Citation Analysis]
142 Jonas S, Neuhaus P. The perspective of liver transplantation for cholangiocarcinoma. Liver Transpl 2007;13:1358-61. [DOI: 10.1002/lt.21248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
143 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
144 Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007;14:469-475. [PMID: 17909715 DOI: 10.1007/s00534-006-1196-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
145 Molina V, Sampson J, Ferrer J, Sanchez-cabus S, Calatayud D, Pavel MC, Fondevila C, Fuster J, García-valdecasas JC. Tumor de Klatskin: Diagnóstico, evaluación preoperatoria y consideraciones quirúrgicas. Cirugía Española 2015;93:552-60. [DOI: 10.1016/j.ciresp.2015.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
146 Jonas S, Krenzien F, Atanasov G, Hau HM, Gawlitza M, Moche M, Wiltberger G, Pratschke J, Schmelzle M. Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities-preserving parts of liver segment 4. Eur Surg 2018;50:22-9. [PMID: 30459814 DOI: 10.1007/s10353-017-0507-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
147 Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y, Jiang C, Sun X, Xu F, Zhang Y. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer. 2012;130:2155-2163. [PMID: 21387295 DOI: 10.1002/ijc.26019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
148 Leonard GD, O’reilly EM. Biliary tract cancers: current concepts and controversies. Expert Opinion on Pharmacotherapy 2005;6:211-23. [DOI: 10.1517/14656566.6.2.211] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
149 Mejia J, Sucandy I, Steel J, Golas B, Humar A, Lee K, Zeh H, Marsh J, Tsung A. Indications and outcomes of pancreatic surgery after liver transplantation. Clin Transplant 2014;28:330-6. [PMID: 24757720 DOI: 10.1111/ctr.12317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Bouma BE, Tearney G. Clinical Imaging with Optical Coherence Tomography. Academic Radiology 2002;9:942-53. [DOI: 10.1016/s1076-6332(03)80465-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
151 Angelico R, Sensi B, Parente A, Siragusa L, Gazia C, Tisone G, Manzia TM. Vascular Involvements in Cholangiocarcinoma: Tips and Tricks. Cancers (Basel) 2021;13:3735. [PMID: 34359635 DOI: 10.3390/cancers13153735] [Reference Citation Analysis]
152 Valero V 3rd, Cosgrove D, Herman JM, Pawlik TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol 2012;6:481-95. [PMID: 22928900 DOI: 10.1586/egh.12.20] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
153 Cannon RM, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford). 2012;14:142-149. [PMID: 22221577 DOI: 10.1111/j.1477-2574.2011.00419.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
154 Jonas S, Benckert C, Thelen A, Lopez-hänninen E, Rösch T, Neuhaus P. Radical surgery for hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2008;34:263-71. [DOI: 10.1016/j.ejso.2007.09.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
155 Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A Phase II pilot study. Cancer 2003;97:2783-90. [DOI: 10.1002/cncr.11401] [Cited by in Crossref: 118] [Cited by in F6Publishing: 94] [Article Influence: 6.6] [Reference Citation Analysis]
156 Fondevila C, Mans E, Fuster J, Grande L, García-valdecasas J, Ferrer J, Visa J. Tumor de Klatskin con invasión de la vena porta. Utilización de injertos vasculares criopreservados tras la resección quirúrgica radical. Cirugía Española 2001;70:200-5. [DOI: 10.1016/s0009-739x(01)71878-7] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
157 Aydin U, Yedibela S, Yazici P, Aydinli B, Zeytunlu M, Kilic M, Coker A. A new technique of biliary reconstruction after "high hilar resection" of hilar cholangiocarcinoma with tumor extension to secondary and tertiary biliary radicals. Ann Surg Oncol. 2008;15:1871-1879. [PMID: 18454297 DOI: 10.1245/s10434-008-9926-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
158 Lladó L, Ramos E, Torras J, Fabregat J, Jorba R, Valls C, Julià D, Serrano T, Figueras J, Rafecas A. [Radical resection of a hilar cholangiocarcinoma. Indications and results]. Cir Esp 2008;83:139-44. [PMID: 18341903 DOI: 10.1016/s0009-739x(08)70529-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
159 Blanchet MC, Ducerf C, Benoit L, Gérard JP, Baulieux J. [Proximal bile duct cholangiocarcinomas]. Ann Chir. 2000;125:825-831. [PMID: 11244588 DOI: 10.1016/S0003-3944(00)00015-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
160 Wu X, Dong P, Gu J, Li M, Wu W, Lu J, Mu J, Ding Q, Zhang L, Ding Q, Weng H, Liu Y. Combined Portal Vein Resection for Hilar Cholangiocarcinoma: A Meta-analysis of Comparative Studies. J Gastrointest Surg 2013;17:1107-15. [DOI: 10.1007/s11605-013-2202-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
161 Wadsworth CA, Lim A, Taylor-robinson SD, Khan SA. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int 2013;7:377-93. [DOI: 10.1007/s12072-012-9407-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
162 Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in Perioperative Outcome After Hepatic Resection: Analysis of 1500 Consecutive Unselected Cases Over 20 Years. Annals of Surgery 2009;249:995-1002. [DOI: 10.1097/sla.0b013e3181a63c74] [Cited by in Crossref: 155] [Cited by in F6Publishing: 66] [Article Influence: 12.9] [Reference Citation Analysis]
163 Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, Sugae S, Tanaka K, Togo S, Bourquain H. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery. 2007;142:666-675. [PMID: 17981186 DOI: 10.1016/j.surg.2007.05.018] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
164 Yu W, Gu Z, Shi S, Shen N, Zhang Y. Effect evaluation of vascular resection for patients with hilar cholangiocarcinoma: original data and meta-analysis. Cell Biochem Biophys 2014;69:509-16. [PMID: 24510536 DOI: 10.1007/s12013-014-9825-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
165 Bednarsch J, Czigany Z, Lurje I, Amygdalos I, Strnad P, Halm P, Wiltberger G, Ulmer TF, Schulze-Hagen M, Bruners P, Neumann UP, Lurje G. Insufficient future liver remnant and preoperative cholangitis predict perioperative outcome in perihilar cholangiocarcinoma. HPB (Oxford) 2021;23:99-108. [PMID: 32546423 DOI: 10.1016/j.hpb.2020.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
166 Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg. 2011;254:776-81; discussion 781-3. [PMID: 22042470 DOI: 10.1097/sla.0b013e3182368f85] [Cited by in Crossref: 63] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
167 Kurumiya Y, Nagino M, Nozawa K, Kamiya J, Uesaka K, Sano T, Yoshida S, Nimura Y. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer. Surgery. 2003;133:512-520. [PMID: 12773979 DOI: 10.1067/msy.2003.142] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
168 Nimura Y. Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford) 2008;10:183-5. [PMID: 18773051 DOI: 10.1080/13651820801992682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
169 Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am. 2009;18:325-337, ix. [PMID: 19306815 DOI: 10.1016/j.soc.2008.12.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
170 de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118:4737-4747. [PMID: 22415526 DOI: 10.1002/cncr.27492] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 13.2] [Reference Citation Analysis]
171 Boberg KM, Schrumpf E. Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep 2004;6:52-9. [PMID: 14720454 DOI: 10.1007/s11894-004-0026-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
172 Nagakawa Y, Kasuya K, Bunso K, Hosokawa Y, Kuwabara H, Nakagima T, Osakabe H, Tsuchiya T, Itoi T, Tsuchida A. Usefulness of multi-3-dimensional computed tomograms fused with multiplanar reconstruction images and peroral cholangioscopy findings in hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014;21:256-62. [PMID: 24520072 DOI: 10.1002/jhbp.85] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
173 Buckholz AP, Brown RS Jr. Cholangiocarcinoma: Diagnosis and Management. Clin Liver Dis 2020;24:421-36. [PMID: 32620281 DOI: 10.1016/j.cld.2020.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
174 Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagó M, Broelsch CE. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005;7:268-72. [PMID: 18333205 DOI: 10.1080/13651820500372780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
175 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754-762. [PMID: 22367444 DOI: 10.1097/sla.0b013e31824a8d82] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
176 Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg. 2007;14:463-468. [PMID: 17909714 DOI: 10.1007/s00534-006-1195-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
177 Kondo S, Katoh H, Hirano S, Ambo Y, Tanaka E, Okushiba S. Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer. Br J Surg. 2003;90:694-697. [PMID: 12808616 DOI: 10.1002/bjs.4084] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
178 Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212:604-13; discussion 613-6. [PMID: 21463797 DOI: 10.1016/j.jamcollsurg.2010.12.028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
179 Prakash K, Regimbeau J, Belghiti J. Reconstruction of portal vein using a hepatic vein patch graft after combined hepatectomy and portal vein resection. The American Journal of Surgery 2003;185:230-1. [DOI: 10.1016/s0002-9610(02)01360-0] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
180 Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, Nishikimi N, Kamei Y. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115-123. [PMID: 20531001 DOI: 10.1097/sla.0b013e3181e463a7] [Cited by in Crossref: 201] [Cited by in F6Publishing: 65] [Article Influence: 18.3] [Reference Citation Analysis]
181 Kim KB, Choi DW, Heo JS, Han IW, Shin SH, You Y, Park DJ. The impact of portal vein resection on outcome of hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:221-9. [PMID: 34053925 DOI: 10.14701/ahbps.2021.25.2.221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129-140. [PMID: 23059502 DOI: 10.1097/sla.0b013e3182708b57] [Cited by in Crossref: 321] [Cited by in F6Publishing: 139] [Article Influence: 40.1] [Reference Citation Analysis]
183 Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg. 2010;251:281-286. [PMID: 20054275 DOI: 10.1097/sla.0b013e3181be0085] [Cited by in Crossref: 74] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
184 Young AL, Igami T, Senda Y, Adair R, Farid S, Toogood GJ, Prasad KR, Lodge JP. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford). 2011;13:483-493. [PMID: 21689232 DOI: 10.1111/j.1477-2574.2011.00328.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
185 Young AL, Prasad KR, Toogood GJ, Lodge JP. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci. 2010;17:497-504. [PMID: 19859651 DOI: 10.1007/s00534-009-0203-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
186 Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl. 2009;15:1499-1507. [PMID: 19877250 DOI: 10.1002/lt.21887] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
187 Ramacciato G, Corigliano N, Mercantini P, Di Benedetto F, Masetti M, Ercolani G, Lauro A, De Ruvo N, Pinna AD. [Prognostic factors after surgical resection for hilar cholangiocarcinoma]. Ann Chir 2006;131:379-85. [PMID: 16806037 DOI: 10.1016/j.anchir.2006.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
188 He M, Xu X, Feng H, Chen W, Liu H, Zhang Y, Wang J, Geng Z, Qiu Y, Duan W, Li X, Zhi X, Zhu W, Li F, Li J, Li S, He Y, Quan Z, Wang J. Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial. Trials 2019;20:528. [PMID: 31443731 DOI: 10.1186/s13063-019-3605-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
189 Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008;48:308-21. [PMID: 18536057 DOI: 10.1002/hep.22310] [Cited by in Crossref: 470] [Cited by in F6Publishing: 428] [Article Influence: 36.2] [Reference Citation Analysis]
190 Richter JA, Kahaleh M. Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma. World J Gastrointest Endosc. 2010;2:357-361. [PMID: 21173912 DOI: 10.4253/wjge.v2.i11.357] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
191 Ueda J, Chijiiwa K, Nakano K, Zhao G, Tanaka M. Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity. Surgery. 2002;131:564-573. [PMID: 12019411 DOI: 10.1067/msy.2002.123008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
192 Zeile M, Bakal A, Volkmer JE, Stavrou GA, Dautel P, Hoeltje J, Stang A, Oldhafer KJ, Brüning R. Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization-the effect of collaterals on embolized liver volume. Br J Radiol 2016;89:20160306. [PMID: 27730840 DOI: 10.1259/bjr.20160306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
193 Chen P, Li B, Zhu Y, Chen W, Liu X, Li M, Duan X, Yi B, Wang J, Liu C, Luo X, Li X, Li J, Liang L, Yin X, Wang H, Jiang X. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma. Oncotarget 2016;7:37319-30. [PMID: 27144432 DOI: 10.18632/oncotarget.9104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
194 Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey J. Total and segmental liver volume variations: Implications for liver surgery. Surgery 2004;135:404-10. [DOI: 10.1016/j.surg.2003.08.024] [Cited by in Crossref: 174] [Cited by in F6Publishing: 126] [Article Influence: 10.2] [Reference Citation Analysis]
195 Noie T, Sugawara Y, Imamura H, Takayama T, Makuuchi M. Selective versus total drainage for biliary obstruction in the hepatic hilus: an experimental study. Surgery. 2001;130:74-81. [PMID: 11436015 DOI: 10.1067/msy.2001.116028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
196 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 115] [Article Influence: 10.5] [Reference Citation Analysis]
197 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Song SC, Choi DW, Kow AW, Choi SH, Heo JS, Kim WS, Kim MJ. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg. 2013;83:268-274. [PMID: 22943422 DOI: 10.1111/j.1445-2197.2012.06195.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
199 Oguro S, Esaki M, Kishi Y, Nara S, Shimada K, Ojima H, Kosuge T. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma. Ann Surg Oncol 2015;22:1915-24. [PMID: 25404474 DOI: 10.1245/s10434-014-4232-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
200 Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Garcia-Valdelcasas JC, López P. Liver transplantation for hilar cholangiocarcinoma: Spanish experience. Transplant Proc. 2003;35:1821-1822. [PMID: 12962808 DOI: 10.1016/s0041-1345(03)00724-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
201 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. [PMID: 11224627 DOI: 10.1097/00000658-200103000-00013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 187] [Article Influence: 11.1] [Reference Citation Analysis]
202 Weiss MJ, Cosgrove D, Herman JM, Rastegar N, Kamel I, Pawlik TM. Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg. 2014;399:679-692. [PMID: 24962146 DOI: 10.1007/s00423-014-1219-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
203 McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston M. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford). 2013;15:260-264. [PMID: 23458262 DOI: 10.1111/j.1477-2574.2012.00523.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
204 Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol 2008;25:110-22. [PMID: 21326552 DOI: 10.1055/s-2008-1076684] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
205 Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol. 2008;15:3147-3156. [PMID: 18754070 DOI: 10.1245/s10434-008-9998-7] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
206 Miyazawa M, Toshimitsu Y, Torii T, Okada K, Koyama I. Extended right hepatectomy for hilar cholangiocarcinoma with resection of the left hepatic duct prior to hepatic resection. J Surg Oncol. 2006;93:72-75. [PMID: 16353189 DOI: 10.1002/jso.20401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
207 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
208 Jarnagin W, D'angelica M, Blumgart L. Intrahepatic and Extrahepatic Biliary Cancer. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 782-826. [DOI: 10.1016/b978-1-4160-3256-4.50063-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
209 Rassam F, Roos E, van Lienden KP, van Hooft JE, Klümpen HJ, van Tienhoven G, Bennink RJ, Engelbrecht MR, Schoorlemmer A, Beuers UHW, Verheij J, Besselink MG, Busch OR, van Gulik TM. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Arch Surg 2018;403:289-307. [PMID: 29350267 DOI: 10.1007/s00423-018-1649-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
210 Bednarsch J, Kather J, Tan X, Sivakumar S, Cacchi C, Wiltberger G, Czigany Z, Ulmer F, Neumann UP, Heij LR. Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma. Liver Cancer 2021;10:260-74. [PMID: 34239812 DOI: 10.1159/000515303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Thelen A, Scholz A, Benckert C, Weichert W, Dietz E, Wiedenmann B, Neuhaus P, Jonas S. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15:791-799. [PMID: 18172731 DOI: 10.1245/s10434-007-9774-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
212 Sakata J, Wakai T, Matsuda Y, Ohashi T, Hirose Y, Ichikawa H, Kobayashi T, Minagawa M, Kosugi S, Koyama Y, Akazawa K, Ajioka Y. Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2016;23:225-234. [PMID: 25994208 DOI: 10.1245/s10434-015-4609-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
213 Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical treatment of perihilar cholangiocarcinoma in octogenarians: a single center experience. Journal of Hepato-Biliary-Pancreatic Sciences 2013;20:324-31. [DOI: 10.1007/s00534-012-0529-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
214 Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
215 Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D, Rothe JH, Weigelt A, Pech M, Langrehr J, Podrabsky P, Neuhaus P, Hänninen EL. Arterial Versus Portal Venous Embolization for Induction of Hepatic Hypertrophy before Extended Right Hemihepatectomy in Hilar Cholangiocarcinomas: A Prospective Randomized Study. Journal of Vascular and Interventional Radiology 2011;22:1254-62. [DOI: 10.1016/j.jvir.2011.04.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
216 Sandanayake NS, Sinclair J, Andreola F, Chapman MH, Xue A, Webster GJ, Clarkson A, Gill A, Norton ID, Smith RC, Timms JF, Pereira SP. A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. Br J Cancer 2011;105:1370-8. [PMID: 21970875 DOI: 10.1038/bjc.2011.376] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
217 Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787-794. [PMID: 18036765 DOI: 10.1016/j.ejso.2007.10.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
218 Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007;14:455-462. [PMID: 17909713 DOI: 10.1007/s00534-006-1194-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
219 Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720-727. [PMID: 14578735 DOI: 10.1097/01.sla.0000094437.68038.a3] [Cited by in Crossref: 255] [Cited by in F6Publishing: 211] [Article Influence: 14.2] [Reference Citation Analysis]
220 Machado MA, Makdissi FF, Surjan RC, Mochizuki M. Laparoscopic resection of hilar cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2012;22:954-956. [PMID: 23101791 DOI: 10.1089/lap.2012.0339] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
221 Hirano S, Tanaka E, Shichinohe T, Suzuki O, Hazama K, Kitagami H, Okamura K, Yano T, Kondo S. Treatment strategy for hilar cholangiocarcinoma, with special reference to the limits of ductal resection in right-sided hepatectomies. J Hepatobiliary Pancreat Surg 2007;14:429-33. [PMID: 17909709 DOI: 10.1007/s00534-006-1190-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
222 Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006;93:1488-1494. [PMID: 17048280 DOI: 10.1002/bjs.5482] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
223 Poneros JM, Tearney GJ, Shiskov M, Kelsey PB, Lauwers GY, Nishioka NS, Bouma BE. Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc 2002;55:84-8. [PMID: 11756925 DOI: 10.1067/mge.2002.120098] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
224 Matthaei H, Lingohr P, Strässer A, Dietrich D, Rostamzadeh B, Glees S, Roering M, Möhring P, Scheerbaum M, Stoffels B. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch. 2015;466:133-141. [PMID: 25425476 DOI: 10.1007/s00428-014-1689-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
225 Bachellier P, Rosso E, Pessaux P, Oussoultzoglou E, Nobili C, Panaro F, Jaeck D. Risk factors for liver failure and mortality after hepatectomy associated with portal vein resection. Ann Surg. 2011;253:173-179. [PMID: 21233614 DOI: 10.1097/sla.0b013e3181f193ba] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
226 Chen Y, Ma L, He Q, Zhang S, Zhang C, Jia W. TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma. Biol Res 2015;48:26. [PMID: 25993985 DOI: 10.1186/s40659-015-0016-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
227 Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Buettner S, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium. World J Surg 2018;42:2919-29. [PMID: 29404753 DOI: 10.1007/s00268-018-4530-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
228 Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg 2015;19:866-79. [PMID: 25605416 DOI: 10.1007/s11605-014-2741-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
229 Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2014;24:411-416. [PMID: 24784226 DOI: 10.1089/lap.2013.0574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
230 Stavrou GA, Donati M, Ringe KI, Peitgen HO, Oldhafer KJ. Liver remnant hypertrophy induction--how often do we really use it in the time of computer assisted surgery? Adv Med Sci. 2012;57:251-258. [PMID: 23314563 DOI: 10.2478/v10039-012-0057-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
231 Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y, Nagino M. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery. 2010;147:49-56. [PMID: 19767048 DOI: 10.1016/j.surg.2009.06.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
232 Fukami Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Salvage hepatectomy for perihilar malignancy treated initially with biliary self-expanding metallic stents. Surgery. 2013;153:627-633. [PMID: 23270971 DOI: 10.1016/j.surg.2012.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
233 Halazun KJ, Al-Mukhtar A, Aldouri A, Malik HZ, Attia MS, Prasad KR, Toogood GJ, Lodge JP. Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg 2007;246:1065-74. [PMID: 18043112 DOI: 10.1097/SLA.0b013e3181492795] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
234 Kaneoka Y, Yamaguchi A, Isogai M, Kumada T. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg. 2010;34:2662-2670. [PMID: 20607255 DOI: 10.1007/s00268-010-0702-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
235 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007;13:1505-15. [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
236 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Reference Citation Analysis]
237 Ku D, Tang R, Pang T, Pleass H, Richardson A, Yuen L, Lam V. Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma. ANZ J Surg 2020;90:1604-14. [PMID: 31840387 DOI: 10.1111/ans.15531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Dokmak S, Ftériche FS, Borscheid R, Cauchy F, Farges O, Belghiti J. 2012 Liver resections in the 21st century: we are far from zero mortality. HPB (Oxford). 2013;15:908-915. [PMID: 23461811 DOI: 10.1111/hpb.12069] [Cited by in Crossref: 106] [Cited by in F6Publishing: 75] [Article Influence: 13.3] [Reference Citation Analysis]
239 Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol. 2012;105:91-96. [PMID: 21815152 DOI: 10.1002/jso.22054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
240 Hameed A, Pang T, Chiou J, Pleass H, Lam V, Hollands M, Johnston E, Richardson A, Yuen L. Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis. HPB (Oxford) 2016;18:400-10. [PMID: 27154803 DOI: 10.1016/j.hpb.2016.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 9.4] [Reference Citation Analysis]
241 De Lu C, Huang J, Wu SD, Hua YF, Javed AA, Fang JZ, Wang CN, Ye S. Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video). J Gastrointest Surg 2017;21:1906-14. [PMID: 28875398 DOI: 10.1007/s11605-017-3561-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Kiesslich T, Neureiter D, Alinger B, Jansky GL, Berlanda J, Mkrtchyan V, Ocker M, Plaetzer K, Berr F. Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation. Photochem Photobiol Sci 2010;9:734-43. [PMID: 20358123 DOI: 10.1039/b9pp00201d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
243 Neuhaus P, Thelen A. Radical surgery for right-sided klatskin tumor. HPB (Oxford). 2008;10:171-173. [PMID: 18773048 DOI: 10.1080/13651820801992708] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
244 Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am. 2010;90:251-263. [PMID: 20362785 DOI: 10.1016/j.suc.2010.01.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
245 Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Gastrointest Endosc Clin N Am. 2005;15:497-511, viii-viix. [PMID: 15990054 DOI: 10.1016/j.giec.2005.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
246 Ebata T, Ito T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Surgical technique of hepatectomy combined with simultaneous resection of hepatic artery and portal vein for perihilar cholangiocarcinoma (with video). J Hepatobiliary Pancreat Sci 2014;21:E57-61. [PMID: 24912472 DOI: 10.1002/jhbp.121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
247 Akamatsu N, Sugawara Y, Osada H, Okada T, Itoyama S, Komagome M, Shin N, Cho N, Ishida T, Ozawa F, Hashimoto D. Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma. J Gastroenterol Hepatol 2010;25:731-7. [PMID: 20074166 DOI: 10.1111/j.1440-1746.2009.06113.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
248 Fritscher-ravens A, Broering DC, Sriram PV, Topalidis T, Jaeckle S, Thonke F, Soehendra N. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: A case series. Gastrointestinal Endoscopy 2000;52:534-40. [DOI: 10.1067/mge.2000.109589] [Cited by in Crossref: 123] [Cited by in F6Publishing: 95] [Article Influence: 5.9] [Reference Citation Analysis]
249 Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. British Journal of Surgery 2010;97:1363-8. [DOI: 10.1002/bjs.7122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
250 Malinowski M, Lock JF, Seehofer D, Gebauer B, Schulz A, Demirel L, Bednarsch J, Stary V, Neuhaus P, Stockmann M. Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization. Surg Today 2016;46:1053-61. [PMID: 26721255 DOI: 10.1007/s00595-015-1293-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
251 Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012;18:594-601. [PMID: 22140024 DOI: 10.1002/lt.22462] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
252 Gringeri E, Bassi D, D'Amico FE, Boetto R, Polacco M, Lodo E, D'Amico F, Vitale A, Boccagni P, Zanus G, Cillo U. Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival. Transplant Proc 2011;43:1187-9. [PMID: 21620084 DOI: 10.1016/j.transproceed.2011.01.140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
253 Hemming AW, Kim RD, Mekeel KL, Fujita S, Reed AI, Foley DP, Howard RJ. Portal Vein Resection for Hilar Cholangiocarcinoma. The American Surgeon 2006;72:599-605. [DOI: 10.1177/000313480607200706] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
254 Wang W, Fei Y, Liu J, Yu T, Tang J, Wei F. Laparoscopic surgery and robotic surgery for hilar cholangiocarcinoma: an updated systematic review. ANZ J Surg 2021;91:42-8. [PMID: 32395906 DOI: 10.1111/ans.15948] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
255 Kim KM, Park JW, Lee JK, Lee KH, Lee KT, Shim SG. A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic vs Percutaneous Transhepatic Biliary Drainage. Gut Liver. 2015;9:791-799. [PMID: 26087784 DOI: 10.5009/gnl14243] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
256 Rocha FG, Matsuo K, Blumgart LH, Jarnagin WR. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci 2010;17:490-6. [PMID: 19806295 DOI: 10.1007/s00534-009-0205-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 6.7] [Reference Citation Analysis]
257 Molina V, Sampson J, Ferrer J, Díaz A, Ayuso JR, Sánchez-Cabús S, Fuster J, García-Valdecasas JC. Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection. Langenbecks Arch Surg 2017;402:95-104. [PMID: 28012034 DOI: 10.1007/s00423-016-1542-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
258 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
259 Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol 2013;19:9209-15. [PMID: 24409049 DOI: 10.3748/wjg.v19.i48.9209] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
260 Robles R, Marín C, Fernández JA, Ramírez P, Sánchez-Bueno F, Morales D, Luján JA, Abellán B, Ramírez M, Cascales P, Pérez D, Parrilla P. [Toward zero mortality in liver resection. Presentation of 200 consecutive cases]. Cir Esp 2005;78:19-27. [PMID: 16420786 DOI: 10.1016/s0009-739x(05)70879-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
261 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
262 Robles Campos R, Brusadin R, López Conesa A, Parrilla Paricio P. Staged liver resection for perihilar liver tumors using a tourniquet in the umbilical fissure and sequential portal vein embolization on the fourth postoperative day (a modified ALTPS). Cir Esp. 2014;92:682-686. [PMID: 25151854 DOI: 10.1016/j.ciresp.2014.07.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
263 Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg 2009;16:502-7. [PMID: 19360368 DOI: 10.1007/s00534-009-0093-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
264 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 19.4] [Reference Citation Analysis]
265 Hu HJ, Jin YW, Zhou RX, Ma WJ, Yang Q, Wang JK, Liu F, Cheng NS, Li FY. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg 2019;23:510-7. [PMID: 30076591 DOI: 10.1007/s11605-018-3892-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
266 Kuriyama N, Isaji S, Tanemura A, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H. Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction. J Gastrointest Surg 2017;21:590-9. [PMID: 27896655 DOI: 10.1007/s11605-016-3332-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
267 Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut 2020;69:52-61. [PMID: 30971436 DOI: 10.1136/gutjnl-2018-317817] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
268 Kiesslich T, Wolkersdörfer G, Neureiter D, Salmhofer H, Berr F. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci 2009;8:23-30. [PMID: 19247524 DOI: 10.1039/b813183j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
269 Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Predictive factors for prognosis of hilar cholangiocarcinoma: Postresection radiotherapy improves survival. European Journal of Surgical Oncology (EJSO) 2007;33:202-7. [DOI: 10.1016/j.ejso.2006.09.033] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
270 Seehofer D, Kamphues C, Neuhaus P. Management of bile duct tumors. Expert Opin Pharmacother. 2008;9:2843-2856. [PMID: 18937616 DOI: 10.1517/14656566.9.16.2843] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
271 Regimbeau JM, Fuks D, Le Treut YP, Bachellier P, Belghiti J, Boudjema K, Baulieux J, Pruvot FR, Cherqui D, Farges O; AFC-HC study group. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg. 2011;15:480-488. [PMID: 21249527 DOI: 10.1007/s11605-011-1414-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
272 Schoppmeyer K, Miethe S, Wiedmann M, Liebmann A, Hauss J, Mossner J, Caca K, Witzigmann H, Hildebrandt G. Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial. Am J Clin Oncol. 2006;29:576-582. [PMID: 17148994 DOI: 10.1097/01.coc.0000239167.17922.82] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
273 Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma. Annals of Surgery 2021;273:572-8. [DOI: 10.1097/sla.0000000000003305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
274 Hoffmann K, Luible S, Goeppert B, Weiss K, Hinz U, Büchler MW, Schemmer P. Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma. Surgery 2015;158:1252-60. [DOI: 10.1016/j.surg.2015.04.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
275 Oussoultzoglou E, Jaeck D. Patient preparation before surgery for cholangiocarcinoma. HPB (Oxford) 2008;10:150-3. [PMID: 18773043 DOI: 10.1080/13651820801992559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
276 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
277 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
278 Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, Nagino M. Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010;17:449-454. [PMID: 19806294 DOI: 10.1007/s00534-009-0209-0] [Cited by in Crossref: 130] [Cited by in F6Publishing: 106] [Article Influence: 10.8] [Reference Citation Analysis]
279 Matsumoto N, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma. Br J Surg. 2014;101:261-268. [PMID: 24399779 DOI: 10.1002/bjs.9383] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
280 Kim NH, Lee SR, Kim YH, Kim HJ. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma. Korean J Radiol 2020;21:1355-66. [PMID: 32767862 DOI: 10.3348/kjr.2019.0891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
281 Endo I, Matsuyama R, Taniguchi K, Sugita M, Takeda K, Tanaka K, Shimada H. Right hepatectomy with resection of caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012;19:216-24. [DOI: 10.1007/s00534-011-0481-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
282 Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602-1608. [PMID: 21964888 DOI: 10.1245/s10434-011-2077-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 129] [Article Influence: 15.9] [Reference Citation Analysis]
283 Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210-218. [PMID: 19638920 DOI: 10.1097/sla.0b013e3181afe0ab] [Cited by in Crossref: 153] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
284 Chryssou E, Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinoma: MR correlation with surgical and histological findings. Clin Radiol. 2010;65:781-788. [PMID: 20797463 DOI: 10.1016/j.crad.2010.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
285 Robles R, Marín C, Pastor P, Ramírez P, Sanchez-Bueno F, Pons JA, Parrilla P. Liver transplantation for Klatskin's tumor: contraindicated, palliative, or indicated? Transplant Proc 2007;39:2293-4. [PMID: 17889167 DOI: 10.1016/j.transproceed.2007.06.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
286 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol. 2011;2:94-107. [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
287 Boland B, Kim A, Nissen N, Colquhoun S. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon 2012;78:157-60. [DOI: 10.1177/000313481207800231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
288 Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273-279. [PMID: 18650638 DOI: 10.1097/sla.0b013e31817f2bfd] [Cited by in Crossref: 120] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
289 Takamoto T, Hashimoto T, Makuuchi M. Left hepatectomy after right paramedian sectoriectomy. Surg Today 2017;47:1533-8. [PMID: 28667439 DOI: 10.1007/s00595-017-1561-3] [Reference Citation Analysis]
290 Li J, Kuehl H, Grabellus F, Müller SP, Radunz S, Antoch G, Nadalin S, Broelsch CE, Gerken G, Paul A, Kaiser GM. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008;98:438-43. [DOI: 10.1002/jso.21136] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
291 Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg 2014;399:707-16. [DOI: 10.1007/s00423-014-1216-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
292 Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000;19:189-99. [DOI: 10.1002/1098-2388(200009)19:2<189::aid-ssu10>3.0.co;2-u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
293 Azoulay D, Pascal G, Salloum C, Adam R, Castaing D, Tranecol N. Vascular reconstruction combined with liver resection for malignant tumours. Br J Surg. 2013;100:1764-1775. [PMID: 24227362 DOI: 10.1002/bjs.9295] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
294 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014;5:344-54. [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
295 Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215:343-355. [PMID: 22749003 DOI: 10.1016/j.jamcollsurg.2012.05.025] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 14.0] [Reference Citation Analysis]
296 Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J. Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int 2008;105:156-61. [PMID: 19633782 DOI: 10.3238/arztebl.2008.0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
297 Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31:1256-1263. [PMID: 17453285 DOI: 10.1007/s00268-007-9001-y] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 9.2] [Reference Citation Analysis]
298 Chopra S, Mathew AS, Engineer R, Shrivastava SK. Positioning high-dose radiation in multidisciplinary management of unresectable cholangiocarcinomas: review of current evidence. Indian J Gastroenterol 2014;33:401-7. [PMID: 25135161 DOI: 10.1007/s12664-014-0495-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
299 Seehofer D, Kamphues C, Neuhaus P. [Resection of Klatskin tumors]. Chirurg 2012;83:221-8. [PMID: 22406679 DOI: 10.1007/s00104-011-2177-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
300 Franken LC, Benzing C, Krenzien F, Schmelzle M, van Dieren S, Olthof PB, van Gulik TM, Pratschke J. Right-sided resection with standard or selective portal vein resection in patients with perihilar cholangiocarcinoma: a propensity score analysis. HPB (Oxford) 2021:S1365-182X(21)00611-0. [PMID: 34330643 DOI: 10.1016/j.hpb.2021.06.429] [Reference Citation Analysis]
301 Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg. 2018;105:829-838. [PMID: 28488733 DOI: 10.1002/bjs.10556] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 11.8] [Reference Citation Analysis]
302 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632.d3] [Cited by in Crossref: 777] [Cited by in F6Publishing: 642] [Article Influence: 55.5] [Reference Citation Analysis]
303 Stavrou GA, Donati M, Faiss S, Jenner RM, Niehaus KJ, Oldhafer KJ. [Perihilar cholangiocarcinoma (Klatskin tumor)]. Chirurg 2014;85:155-65; quiz 166-7. [PMID: 24464335 DOI: 10.1007/s00104-012-2390-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
304 Kondo S, Hirano S, Ambo Y, Tanaka E, Kubota T, Katoh H. Arterioportal shunting as an alternative to microvascular reconstruction after hepatic artery resection. British Journal of Surgery 2004;91:248-51. [DOI: 10.1002/bjs.4428] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
305 Abu Hilal M, Lodge J. Pushing back the frontiers of resectability in liver cancer surgery. European Journal of Surgical Oncology (EJSO) 2008;34:272-80. [DOI: 10.1016/j.ejso.2007.07.201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
306 Fukami Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Suzuki K, Nagino M. Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci 2012;19:179-86. [PMID: 21681648 DOI: 10.1007/s00534-011-0413-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
307 Pinson CW, Moore DE. Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 2003;5:203-5. [PMID: 18332988 DOI: 10.1080/13651820310019938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
308 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
309 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol. 2013;5:147-158. [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
310 Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, Miyamoto N. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 2003;57:1357-65. [PMID: 14630274 DOI: 10.1016/s0360-3016(03)00770-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
311 Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma. Surg Oncol Clin N Am 2014;23:247-63. [PMID: 24560109 DOI: 10.1016/j.soc.2013.10.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
312 Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg. 2009;394:1065-1072. [PMID: 19169703 DOI: 10.1007/s00423-009-0464-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
313 Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463-1466. [PMID: 11683741 DOI: 10.1046/j.0007-1323.2001.01879.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 6.3] [Reference Citation Analysis]
314 Mantel HT, Westerkamp AC, Sieders E, Peeters PM, de Jong KP, Boer MT, de Kleine RH, Gouw AS, Porte RJ. Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value. Cancer Med 2016;5:1373-80. [PMID: 27062713 DOI: 10.1002/cam4.693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
315 Sugiura T, Nishio H, Nagino M, Senda Y, Ebata T, Yokoyama Y, Igami T, Oda K, Nimura Y. Value of Multidetector-row Computed Tomography in Diagnosis of Portal Vein Invasion by Perihilar Cholangiocarcinoma. World J Surg 2008;32:1478-84. [PMID: 18347849 DOI: 10.1007/s00268-008-9547-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
316 Sarmiento JM, Nagorney DM. Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surgical Oncology Clinics of North America 2002;11:893-908. [DOI: 10.1016/s1055-3207(02)00034-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
317 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
318 Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, Florman S, Ward SC, Thung SN, Fiel M, Schiano TD. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation. 2015;99:151-157. [PMID: 25029385 DOI: 10.1097/tp.0000000000000286] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 6.2] [Reference Citation Analysis]
319 Shimamura K, Kurosaki I, Sato D, Takano K, Yokoyama N, Sato Y, Hatakeyama K, Nakadaira K, Yagi M. Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case. Surg Today. 2009;39:247-251. [PMID: 19280286 DOI: 10.1007/s00595-008-3825-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
320 Dai WC, Chok KS, Cheung TT, Chan AC, Chan SC, Lo CM. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017;16:382-386. [PMID: 28823368 DOI: 10.1016/s1499-3872(17)60039-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
321 Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189-200. [PMID: 21460876 DOI: 10.1038/nrgastro.2011.20] [Cited by in Crossref: 204] [Cited by in F6Publishing: 181] [Article Influence: 20.4] [Reference Citation Analysis]
322 Kurosaki I, Hatakeyama K, Minagawa M, Sato D. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008;12:907-918. [PMID: 17968629 DOI: 10.1007/s11605-007-0387-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
323 Endo I, Sugita M, Masunari H, Yoshida K, Takeda K, Sekido H, Togo S, Shimada H. Retroportal hepaticojejunostomy for extended resection of hilar bile ducts. J Gastrointest Surg. 2008;12:962-965. [PMID: 17963011 DOI: 10.1007/s11605-007-0388-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
324 Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Misuta K, Sekido H, Togo S. Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg. 2003;27:1137-1142. [PMID: 12925900 DOI: 10.1007/s00268-003-6801-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
325 Murakami Y, Uemura K, Hayasidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. Dig Dis Sci. 2009;54:1360-1364. [PMID: 18975086 DOI: 10.1007/s10620-008-0492-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
326 Jonas S, Mittler J, Pascher A, Theruvath T, Thelen A, Klupp J, Langrehr JM, Neuhaus P. Extended indications in living-donor liver transplantation: bile duct cancer. Transplantation. 2005;80:S101-S104. [PMID: 16286884 DOI: 10.1097/01.tp.0000187106.29908.2b] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
327 Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75:981-985. [PMID: 16336393 DOI: 10.1111/j.1445-2197.2005.03595.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
328 de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg. 2011;146:697-703. [PMID: 21690446 DOI: 10.1001/archsurg.2011.122] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
329 Zori AG, Yang D, Draganov PV, Cabrera R. Advances in the management of cholangiocarcinoma. WJH 2021;13:1003-18. [DOI: 10.4254/wjh.v13.i9.1003] [Reference Citation Analysis]
330 Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg. 2007;193:702-706. [PMID: 17512280 DOI: 10.1016/j.amjsurg.2006.10.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
331 Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005;241:703-12; discussion 712-4. [PMID: 15849506 DOI: 10.1097/01.sla.0000160817.94472.fd] [Cited by in Crossref: 141] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
332 Lee SH, Choi GH, Han DH, Kim KS, Choi JS, Rho SY. Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:62-70. [PMID: 33649256 DOI: 10.14701/ahbps.2021.25.1.62] [Reference Citation Analysis]
333 Vauthey JN, Zimmitti G, Shindoh J. From Couinaud to molecular biology: the seven virtues of hepato-pancreato-biliary surgery. HPB (Oxford). 2012;14:493-499. [PMID: 22762396 DOI: 10.1111/j.1477-2574.2012.00502.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
334 Sapisochin G, Ivanics T, Subramanian V, Doyle M, Heimbach JK, Hong JC. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles. Int J Surg 2020;82S:77-81. [PMID: 32380231 DOI: 10.1016/j.ijsu.2020.04.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
335 Nagorney DM, Kendrick ML. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg. 2006;40:159-171. [PMID: 17163100 DOI: 10.1016/j.yasu.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
336 Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D’Angelica M, Fong Y. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11:445-451. [PMID: 19768150 DOI: 10.1111/j.1477-2574.2009.00090.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
337 de Santibañes E, Ardiles V, Alvarez FA, Pekolj J, Brandi C, Beskow A. Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy. HPB (Oxford) 2012;14:67-70. [PMID: 22151454 DOI: 10.1111/j.1477-2574.2011.00404.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
338 Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329-337. [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
339 Nagino M, Ebata T, Mizuno T. Oncological Superiority of Right-sided Hepatectomy Over Left-sided Hepatectomy as Surgery for Perihilar Cholangiocarcinoma: Truth or Biased View? Ann Surg 2021;274:31-2. [PMID: 33214439 DOI: 10.1097/SLA.0000000000004534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101. [PMID: 15213624 DOI: 10.1097/01.sla.0000129491.43855.6b] [Cited by in Crossref: 219] [Cited by in F6Publishing: 185] [Article Influence: 12.9] [Reference Citation Analysis]
341 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72] [Cited by in Crossref: 164] [Cited by in F6Publishing: 108] [Article Influence: 9.1] [Reference Citation Analysis]
342 Sakamoto Y, Sano T, Shimada K, Kosuge T, Kimata Y, Sakuraba M, Yamamoto J, Ojima H. Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg. 2006;391:203-208. [PMID: 16525853 DOI: 10.1007/s00423-006-0026-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
343 Bartsch F, Heinrich S, Lang H. Limits of Surgical Resection for Bile Duct Cancer. Viszeralmedizin 2015;31:189-93. [PMID: 26468314 DOI: 10.1159/000433482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
344 Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg. 2007;246:1052-1057. [PMID: 18043110 DOI: 10.1097/sla.0b013e318142d97e] [Cited by in Crossref: 78] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
345 Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schäfer H, Buchert R, Rogiers X, Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001;22:1277-85. [PMID: 11711897 DOI: 10.1097/00006231-200112000-00002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
346 Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? Dig Dis Sci. 2011;56:663-672. [PMID: 20635143 DOI: 10.1007/s10620-010-1338-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
347 Nooijen LE, Swijnenburg RJ, Klümpen HJ, Verheij J, Kazemier G, van Gulik TM, Erdmann JI. Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art. Visc Med 2021;37:18-25. [PMID: 33708815 DOI: 10.1159/000514032] [Reference Citation Analysis]
348 Hirose T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Mori K, Ando M, Nagino M. Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg 2015;39:2983-9. [PMID: 26296838 DOI: 10.1007/s00268-015-3201-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
349 Nagino M. Fifty-year history of biliary surgery. Ann Gastroenterol Surg. 2019;3:598-605. [PMID: 31788648 DOI: 10.1002/ags3.12289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
350 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/00000658-200307000-00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
351 Wagner A, Mayr C, Bach D, Illig R, Plaetzer K, Berr F, Pichler M, Neureiter D, Kiesslich T. MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci 2014;15:20134-57. [PMID: 25380521 DOI: 10.3390/ijms151120134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
352 Benzing C, Krenzien F, Mieg A, Wolfsberger A, Andreou A, Nevermann N, Pelzer U, Fehrenbach U, Haiden LM, Öllinger R, Schöning W, Schmelzle M, Pratschke J. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch Surg 2021;406:1499-509. [PMID: 34075473 DOI: 10.1007/s00423-021-02154-4] [Reference Citation Analysis]
353 Sucher R, Scheuermann U, Seehofer D. Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy. Ann Surg Oncol 2021;28:2030-4. [PMID: 33000370 DOI: 10.1245/s10434-020-09175-1] [Reference Citation Analysis]
354 Aoki T, Sakamoto Y, Kohno Y, Akamatsu N, Kaneko J, Sugawara Y, Hasegawa K, Makuuchi M, Kokudo N. Hepatopancreaticoduodenectomy for Biliary Cancer: Strategies for Near-zero Operative Mortality and Acceptable Long-term Outcome. Ann Surg. 2018;267:332-337. [PMID: 27811506 DOI: 10.1097/sla.0000000000002059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
355 Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kawasaki R. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17:455-462. [PMID: 19820891 DOI: 10.1007/s00534-009-0208-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 8.6] [Reference Citation Analysis]
356 Chung YE, Kim MJ, Park YN, Lee YH, Choi JY. Staging of extrahepatic cholangiocarcinoma. Eur Radiol. 2008;18:2182-2195. [PMID: 18458911 DOI: 10.1007/s00330-008-1006-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
357 Masunari H, Shimada H, Endo I, Fujii Y, Tanaka K, Sekido H, Togo S. Surgical Anatomy of Hepatic Hilum with Special Reference of the Plate System and Extrahepatic Duct. J Gastrointest Surg 2008;12:1047-53. [DOI: 10.1007/s11605-007-0358-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
358 Malago M, Frilling A, Li J, Lang H, Broelsch CE. Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford). 2008;10:179-182. [PMID: 18773050 DOI: 10.1080/13651820801992500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
359 Kim YJ, Kim K, Min SK, Nam EM. Role of adjuvant radiotherapy for localized extrahepatic bile duct cancer. Br J Radiol. 2017;90:20160807. [PMID: 28118028 DOI: 10.1259/bjr.20160807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
360 Mekeel KL, Hemming AW. Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy. Hepat Oncol 2014;1:53-65. [PMID: 30190941 DOI: 10.2217/hep.13.5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
361 Bednarsch J, Czigany Z, Heij LR, Luedde T, Wiltberger G, Dulk MD, Bruners P, Lang SA, Ulmer TF, Neumann UP. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma. HPB (Oxford) 2021:S1365-182X(21)00094-0. [PMID: 33934958 DOI: 10.1016/j.hpb.2021.03.012] [Reference Citation Analysis]
362 Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006;243:364-72. [PMID: 16495702 DOI: 10.1097/01.sla.0000201482.11876.14] [Cited by in Crossref: 363] [Cited by in F6Publishing: 304] [Article Influence: 24.2] [Reference Citation Analysis]
363 Atanasov G, Schierle K, Hau HM, Dietel C, Krenzien F, Brandl A, Wiltberger G, Englisch JP, Robson SC, Reutzel-Selke A, Pascher A, Jonas S, Pratschke J, Benzing C, Schmelzle M. Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma. Ann Surg Oncol 2017;24:518-25. [PMID: 27480355 DOI: 10.1245/s10434-016-5472-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
364 Sperling J, Ziemann C, Schuld J, Laschke MW, Schilling MK, Menger MD, Kollmar O. A comparative evaluation of ablations produced by high-frequency coagulation-, argon plasma coagulation-, and cryotherapy devices in porcine liver. Int J Colorectal Dis 2012;27:1229-35. [PMID: 22648175 DOI: 10.1007/s00384-012-1504-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
365 Ramacciato G, Nigri G, Bellagamba R, Petrucciani N, Ravaioli M, Cescon M, Del Gaudio M, Ercolani G, Di Benedetto F, Cautero N, Quintini C, Cucchetti A, Lauro A, Miller C, Pinna AD. Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma. The American Surgeon 2010;76:1260-8. [DOI: 10.1177/000313481007601129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
366 Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:254-258. [PMID: 18333202 DOI: 10.1080/13651820500373093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
367 Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, Clavien PA. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363-1371. [PMID: 21480336 DOI: 10.1002/hep.24227] [Cited by in Crossref: 187] [Cited by in F6Publishing: 148] [Article Influence: 18.7] [Reference Citation Analysis]
368 Kovalenko YA, Zharikov YO, Kukeev IA, Vishnevsky VA, Chzhao AV. [Predictors of outcomes in surgery for hilar cholangiocarcinoma]. Khirurgiia (Mosk). 2018;5-11. [PMID: 30531729 DOI: 10.17116/hirurgia20181015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
369 Passeri MJ, Baimas-George MR, Sulzer JK, Iannitti DA, Martinie JB, Baker EH, Ocuin LM, Vrochides D. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2020;19:157-62. [PMID: 32088126 DOI: 10.1016/j.hbpd.2020.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-247. [PMID: 16858186 DOI: 10.1097/01.sla.0000217605.66519.38] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 10.9] [Reference Citation Analysis]
371 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632] [Reference Citation Analysis]
372 Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488-1496; discussion 1496-1497. [PMID: 17805937 DOI: 10.1007/s11605-007-0282-0] [Cited by in Crossref: 148] [Cited by in F6Publishing: 145] [Article Influence: 10.6] [Reference Citation Analysis]
373 Thelen A, Scholz A, Benckert C, Schröder M, Weichert W, Wiedenmann B, Neuhaus P, Jonas S. Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. J Gastroenterol 2008;43:959-66. [PMID: 19107340 DOI: 10.1007/s00535-008-2255-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
374 Caillol F, Bories E, Poizat F, Pesenti C, Esterni B, Monges G, Giovannini M. Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients. United European Gastroenterol J. 2013;1:120-127. [PMID: 24917949 DOI: 10.1177/2050640613483462] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
375 Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79-88. [PMID: 24375300 DOI: 10.1002/bjs.9379] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
376 Sugiura T, Uesaka K, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Otsuka S, Nakagawa M, Aramaki T, Asakura K. Major hepatectomy with combined vascular resection for perihilar cholangiocarcinoma. BJS Open 2021;5:zrab064. [PMID: 34355240 DOI: 10.1093/bjsopen/zrab064] [Reference Citation Analysis]
377 Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714. [PMID: 17060763 DOI: 10.1097/01.sla.0000219039.20924.88] [Cited by in Crossref: 219] [Cited by in F6Publishing: 169] [Article Influence: 14.6] [Reference Citation Analysis]
378 Yasuda Y, Larsen PN, Ishibashi T, Yamashita K, Toei H. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery. HPB (Oxford) 2010;12:147-52. [PMID: 20495660 DOI: 10.1111/j.1477-2574.2009.00152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
379 Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310-320. [PMID: 21871986 DOI: 10.1016/j.amjsurg.2010.08.041] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
380 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
381 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Conci S, Valdegamberi A, Sandri M, Iacono C. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford). 2011;13:240-245. [PMID: 21418129 DOI: 10.1111/j.1477-2574.2010.00277.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
382 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
383 Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Nakagawa M, Uesaka K. Left Hepatectomy with Combined Resection and Reconstruction of Right Hepatic Artery for Bismuth Type I and II Perihilar Cholangiocarcinoma. World J Surg 2019;43:894-901. [PMID: 30377720 DOI: 10.1007/s00268-018-4833-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
384 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
385 Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol. 2004;99:45-51. [PMID: 14687140 DOI: 10.1046/j.1572-0241.2003.04006.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 133] [Article Influence: 10.4] [Reference Citation Analysis]
386 Schoppmeyer K, Kreth F, Wiedmann M, Mössner J, Preiss R, Caca K. A pilot study of bendamustine in advanced bile duct cancer. Anti-Cancer Drugs 2007;18:697-702. [DOI: 10.1097/cad.0b013e32803d36e6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]